DI
VRTX icon

DFPG Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

DFPG Investments’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$1.79M Buy
+4,347
New +$1.61M 0.14% 155

Other funds holding VRTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

DFPG Investments's VRTX Position: Q4 2023 in Review

DFPG Investments opened a new position in Vertex Pharmaceuticals (VRTX) in Q4 2023: 4,347 shares worth $1.79M. The stake represents 0.14% of the portfolio and ranks #155 among its holdings.

1,438 funds tracked by Wall St. Rank hold VRTX as of Q4 2023.

  • DFPG Investments held 4,347 shares of Vertex Pharmaceuticals worth $1.79M as of Q4 2023.
  • Vertex Pharmaceuticals was a new DFPG Investments position in Q4 2023.
  • Vertex Pharmaceuticals made up 0.14% of DFPG Investments's portfolio in Q4 2023, its #155 holding.
  • 1,438 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2023.

Based on DFPG Investments's 13F filing for Q4 2023, filed 10 Jan 2024.